Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmut Drexler

Showing results (31-40 of 186) with videos related to

Pageof 19
Sort By:
Journal of Cardiovascular Pharmacology|May 13, 2009
Quo vadis, progenitor? Progenitor cell homing in chronic ischemic heart diseaseFlorian P Limbourg, Helmut Drexler
Cardiovascular Drugs and Therapy|October 11, 2016
Therapeutic advances in heart failureThomas Meinertz, Helmut Drexler, Hanjörg Just
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 20, 2004
Renin-angiotensin system and atherosclerosisKarsten Grote, Helmut Drexler, Bernhard Schieffer
Circulation|June 3, 2004
Endothelial function: a critical determinant in atherosclerosis?Ulf Landmesser, Burkhard Hornig, Helmut Drexler
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 24, 2004
Therapeutic effects of angiotensin (AT1) receptor antagonists: potential contribution of mechanisms other than AT1 receptor blockadeBoris Schmidt, Helmut Drexler, Bernhard Schieffer
Circulation Journal : Official Journal of the Japanese Circulation Society|November 7, 2009
Cell-based therapies for ischemic heart disease--"trick and treat"Anne Limbourg, Florian Limbourg, Helmut Drexler
Biochemical and Biophysical Research Communications|August 14, 2003
5-Lipoxygenase is involved in the angiotensin II-induced NAD(P)H-oxidase activationMaren Luchtefeld, Helmut Drexler, Bernhard Schieffer
Journal of Clinical Hypertension (Greenwich, Conn.)|May 4, 2010
Hypertension as an underlying factor in heart failure with preserved ejection fractionMassimo Volpe, Robert McKelvie, Helmut Drexler
Trends in Cardiovascular Medicine|September 16, 2008
Peripartum cardiomyopathy: recent insights in its pathophysiologyDenise Hilfiker-Kleiner, Karen Sliwa, Helmut Drexler
Cardiovascular Research|November 21, 2008
Potential novel pharmacological therapies for myocardial remodellingUlf Landmesser, Kai C Wollert, Helmut Drexler
Pageof 19

Showing results (31-40 of 186) with videos related to

Sort By:
Pageof 19
Journal of Cardiovascular Pharmacology|May 13, 2009
Quo vadis, progenitor? Progenitor cell homing in chronic ischemic heart diseaseFlorian P Limbourg, Helmut Drexler
Cardiovascular Drugs and Therapy|October 11, 2016
Therapeutic advances in heart failureThomas Meinertz, Helmut Drexler, Hanjörg Just
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 20, 2004
Renin-angiotensin system and atherosclerosisKarsten Grote, Helmut Drexler, Bernhard Schieffer
Circulation|June 3, 2004
Endothelial function: a critical determinant in atherosclerosis?Ulf Landmesser, Burkhard Hornig, Helmut Drexler
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 24, 2004
Therapeutic effects of angiotensin (AT1) receptor antagonists: potential contribution of mechanisms other than AT1 receptor blockadeBoris Schmidt, Helmut Drexler, Bernhard Schieffer
Circulation Journal : Official Journal of the Japanese Circulation Society|November 7, 2009
Cell-based therapies for ischemic heart disease--"trick and treat"Anne Limbourg, Florian Limbourg, Helmut Drexler
Biochemical and Biophysical Research Communications|August 14, 2003
5-Lipoxygenase is involved in the angiotensin II-induced NAD(P)H-oxidase activationMaren Luchtefeld, Helmut Drexler, Bernhard Schieffer
Journal of Clinical Hypertension (Greenwich, Conn.)|May 4, 2010
Hypertension as an underlying factor in heart failure with preserved ejection fractionMassimo Volpe, Robert McKelvie, Helmut Drexler
Trends in Cardiovascular Medicine|September 16, 2008
Peripartum cardiomyopathy: recent insights in its pathophysiologyDenise Hilfiker-Kleiner, Karen Sliwa, Helmut Drexler
Cardiovascular Research|November 21, 2008
Potential novel pharmacological therapies for myocardial remodellingUlf Landmesser, Kai C Wollert, Helmut Drexler
Pageof 19